Take home message: The novel coronavirus can be transmitted from person to person with infection ranging from mild disease to severe pneumonia and radiological abnormalities on chest CT for most patients improved after RT-PCR conversion.
To the Editor
Since an outbreak of 2019 novel coronavirus in Wuhan and related regions in Hubei province, an increasing number of exported cases have been confirmed in other provinces in China and in multiple countries around the world with substantial morbidity and mortality [1] [2] [3] [4] . The WHO has declared a public health emergency of international concern considering rapid increases in numbers of confirmed cases in China and additional countries. As of February 22, 2020, a total of 12938 patients had been confirmed outside of Wuhan and related regions in Hubei province of China [1] . However, there is limited information about COVID-19 outside of Wuhan [5] , and no study has reported the time to RT-PCR conversion and radiological changes after treatment.
We recruited all patients who were diagnosed as having COVID-19 from Jan 21 to 18 patients with COVID-19 were included, with one familial cluster of infection. Of these patients, 10 (55.6%) were male, with a median age of 39 years (interquartile range 29-55). For the familial cluster of infection (including 2 children aged 7 and 9 years), 5 of six family members had been tested positive for SARS-CoV-2 and the remaining one was highly suspected due to bilateral ground-glass opacities on his chest CT but RT-PCR was negative. 13 (72.2%) had a history of visiting to Wuhan. 12 (66.7%) did not have underlying conditions. 6 (33.3%) had chronic comorbidities, On admission, most patients presented as fever (94.4%) or cough (55.6%). Other symptoms included short of breath (22.2%), hemoptysis (5.6%), muscle ache (11.1%), headache (5.6%), sore throat (5.6%), diarrhea (16.7%), nausea and vomiting (5.6%). One patient had acute lung injury and was admitted to ICU.
For laboratory results (data available for 16 patients) and chest CT, white blood cells were below the normal range in 3 (18.8%) and above the normal range in 1 (6.3%). 3 As of Feb 7, 6 (33.3%) patients had been discharged and all the other patients were still in the hospital; and 13 (72.2%) had been fully symptomatic remission and one had developed to severe respiratory failure and been transferred to the ICU.
And one in the ICU on admission had been transferred to general isolated ward on the eighth day of admission.
The median time from symptom onset to admission was 7 days (range 2-15). Of 13 fully symptomatic remission patients, the median time from illness onset to symptom remission was 10 days (range 3-15). Of 6 discharged patients, the median time of RT-PCR conversion were 19.5 days (range 17-24) and interval for two chest CT scans 12.5 days (range 10-15). 5 (83.3%) had significant radiological improvement at the time of RT-PCR conversion and the remaining one had no change on chest CT image (figure 1).
Our results firstly show that time to RT-PCR conversion was 19.5 days for COVID-19 and most patients had significantly radiological improvements after RT-PCR conversion. Consistent with previous studies, most patients manifested as fever, dry cough and short of breath [2] [3] [4] . The patterns of radiological appearance were bilateral ground-glass opacities with or without consolidations [7] . All these features resemble with SARS-CoV and MERS-CoV [8, 9] . However, patients with COVID-19 can present as mild disease or even no symptom, and no lung abnormalities or severe pneumonia on chest CT images. We reported a family cluster infection and some confirmed cases did not have comorbidities and the history of visiting to Wuhan, suggesting human-to-human transmission has been occurred outside of Wuhan regardless of age and underlying conditions [10] [11] [12] . Compared with patients in Wuhan, the manifestations of patients in Henan province are relatively mild [2] [3] [4] , which was consistent with 13 case series of COVID-19 in Beijing [5] . Notably, transmission in asymptomatic carrier has been reported [12] , which might pose more threat than symptomatic patients to epidemic prevention and control.
The median time from symptom onset to RT-PCR conversion in patients with COVID-19 was 19.5 days, which seems to be shorter than patients infected with SARS or MERS-CoV [13, 14] . Previous studies in SARS-CoV or MERS-CoV showed that viral RNA could be detected in clinical specimens in patients >30 days after symptom onset [13, 14] . It was worth mentioning that we only used the throat-swab specimen to detect the viral RNA. Evidence have showed that SARS-CoV-2, SARS or MERS RNA could be detected in both upper and lower respiratory tract samples, even in blood, stool and urine specimens [2, 13, 14] . Because lower respiratory tract was thought to be the main target of coronavirus and viral RNA level is often higher in the lower respiratory tract specimen [15] , we should be cognizant of the potential for 
